Document Detail


Prasugrel as an alternative for clopidogrel-associated neutropenia.
MedLine Citation:
PMID:  21791365     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable hematologic adverse event profile. Prasugrel is the newest thienopyridine approved for use in Canada. This case describes a patient who was diagnosed with an acute coronary syndrome and treated with bare metal stenting of his coronary artery. He was discharged home on clopidogrel therapy. Two weeks later he presented with severe neutropenia. Clopidogrel was discontinued and prasugrel was initiated. Neutrophil count gradually increased and returned to normal. In patients with neutropenia associated with clopidogrel therapy, prasugrel may be considered as an alternative.
Authors:
Sanjiv Khangura; Wendy L Gordon
Related Documents :
17906485 - Treatment of cholesterol crystal embolisation syndrome with filter-assisted stenting.
11142135 - A severe case of vascular thoracic outlet syndrome.
7247565 - Anomalous right subclavian artery arising proximal to a postductal thoracic aortic coar...
21092005 - Transvenous coil embolization of patent ductus arteriosus in small (≤3.0 kg) dogs.
18473715 - Treprostinil for the treatment of pulmonary hypertension.
2181955 - Toward a durable and safe aortic root reconstruction.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-07-24
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  27     ISSN:  1916-7075     ISO Abbreviation:  Can J Cardiol     Publication Date:    2011 Nov-Dec
Date Detail:
Created Date:  2011-11-28     Completed Date:  2012-01-19     Revised Date:  2012-02-28    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  869.e9-11     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Pharmacy, Royal Columbian Hospital, Fraser Health, New Westminster, British Columbia, Canada. sanjiv.khangura@fraserhealth.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / diagnosis,  surgery*
Aged, 80 and over
Coronary Artery Bypass / methods*
Coronary Restenosis / prevention & control*
Follow-Up Studies
Humans
Male
Neutropenia / blood,  chemically induced*,  prevention & control
Piperazines / administration & dosage*
Platelet Aggregation Inhibitors / adverse effects
Purinergic P2Y Receptor Antagonists / administration & dosage*
Stents
Thiophenes / administration & dosage*
Ticlopidine / adverse effects,  analogs & derivatives*,  therapeutic use
Chemical
Reg. No./Substance:
0/Piperazines; 0/Platelet Aggregation Inhibitors; 0/Purinergic P2Y Receptor Antagonists; 0/Thiophenes; 0/prasugrel; 55142-85-3/Ticlopidine; 90055-48-4/clopidogrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between kidney function and angiographically-derived SYNTAX score.
Next Document:  Thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, orotate phosphoribos...